HROGas03 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HROGas03 cell line is derived from the gastric adenocarcinoma of an adult female patient. Gastric adenocarcinoma, a common type of stomach cancer, arises from the glandular epithelial cells of the stomach lining and is often associated with poor prognosis. As a model, HROGas03 provides an invaluable resource for studying the molecular pathways involved in the initiation, progression, and therapeutic resistance of gastric adenocarcinoma. The age-related aspects of the donor, such as potential genomic instability and alterations in tumor microenvironment, can provide unique insights into cancer biology in older individuals. This cell line allows researchers to explore key molecular mechanisms driving gastric cancer, such as mutations in tumor suppressor genes (e.g., TP53), alterations in the cell cycle, and dysregulated signaling pathways, including the Wnt, MAPK, and PI3K/AKT pathways. These pathways are often implicated in the survival, proliferation, and metastatic potential of gastric cancer cells. The HROGas03 cell line can also be used to assess the efficacy of targeted therapies, chemotherapeutic agents, or combination treatments, potentially leading to improved therapeutic strategies for gastric cancer patients, especially in older demographics. |
|---|---|
| Organism | Human |
| Tissue | Stomach |
| Disease | Gastric adenocarcinoma |
Characteristics
| Age | 80 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent/Suspension |
Regulatory Data
| Citation | HROGas03 (Cytion catalog number 300437) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2U70 |
Biomolecular Data
Handling
| Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use 50% basal medium + 40% FBS + 10% DMSO, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Flask Coating | None |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300437-122 | Certificate of Analysis | 23. May. 2025 | 300437 |